A study to assess the prevalence of Herpes Simplex Type 2 (HSV-2) infections in pregnant women in a tertiary care hospital
Keywords:
Herpes Simplex Type 2 (HSV-2), pregnant women, infectionsAbstract
Aim: Assess the prevalence of Herpes Simplex Type 2 (HSV-2) infections in pregnant women in a tertiary care hospital. Methods: There were a total of one hundred pregnant women that participated in this research. 5 ml blood samples were obtained using vein puncture and placed in a sterile plain tube. These samples were then allowed to clot for 30 minutes before being centrifuged at 3000 rpm for 5 minutes. Each of the resulting serums was placed in a fresh vial, given a label, and kept at a temperature of -20 degrees Celsius until it was time for the ELISA analysis. In order to determine whether or not the serum included HSV-2 IgG antibodies, an HSV-2 specific IgG ELISA test kit was used. Results: In this research, 100 pregnant women were recruited. HSV-2 infection was found in 40% of people. The largest infected group was pregnant women under the age of 25, with 57.14 percent infected, and the lowest in older age groups. Housewives had the greatest prevalence (71.79 percent), followed by private workers (32%), while government employees had the lowest seroprevalence (8.33 percent). The relationship between viral infection and employment was statistically significant (p≤ 0.05).
Downloads
References
Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev 2004; 17:1–13. [PubMed: 14726453]
Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333:770–5. [PubMed: 7643884]
American Academy of Pediatrics. Committee on fetus and newborn. Committee on infectious diseases. Perinatal herpes simplex virus infections. Pediatrics 1980; 66:147–9. [PubMed: 7402781]
Whitley RJ, Nahmias AJ, Soong SJ, Galasso GG, Fleming CL, Alford CA. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1980; 66:495–501. [PubMed: 7001331]
Arvin AM, Yeager AS, Bruhn FW, Grossman M. Neonatal herpes simplex infection in the absence of mucocutaneous lesions. J Pediatr 1982; 100:715–21. [PubMed: 7069532]
Sullivan-Bolyai J, Hull HF, Wilson C, Corey L. Neonatal herpes simplex virus infection in King County, Washington. Increasing incidence and epidemiologic correlates. JAMA 1983; 250:3059–62. [PubMed: 6315977]
Hemelaar SJ, Poeran J, Steegers EA, van der Meijden WI. Neonatal herpes infections in the Netherlands in the period 2006–2011. J Matern Fetal Neonatal Med 2014; 11:1–5.
Kropp RY, Wong T, Cormier L, et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 2006; 117:1955–62. [PubMed: 16740836]
Jones C, Raynes Greenow C, Isaacs D. Population-based surveillance of neonatal herpes simplex virus infection in Australia, 1997–2011. Clin Infect Dis 2014; 59:525–31. [PubMed: 24846638]
Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2—United States, 1999–2010. J Infect Dis 2014; 209:325–33. [PubMed: 24136792]
Bernstein DI, Bellamy AR, Hook EW, 3rd, et al. Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis 2013; 56:344–51. [PubMed: 23087395]
Roberts CM, Pfister JR, Spear SJ. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis 2003; 30:797–800. [PubMed: 14520181]
Xu F, Markowitz LE, Gottlieb SL, Berman SM. Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States. Am J Obstet Gynecol 2007; 196:43.e1–6. [PubMed: 17240228]
Idress HEA, Elhag WI. Seroprevalence of herpes simplex virus type 2 among pregnant women attending Ibrahim Malik Teaching Hospital, Khartoum State, Sudan. American Journal of Research Communication. 2015;3(11):149-160
Kim ID, Chang HS, Hwang KJ. Herpes simplex virus type 2 infection rate and necessity of screening during pregnancy: A clinical and seroepidemiologic study. Yonsei Medical Journal. 2012;53(2):401- 407.
Mehmet O, Tasbent FE, Terzi HA, Cetinkol Y, Uysal EB, Asik G, Parlak M, Gulhan B, Ciftci IH. Seroprevalence of major viral pathogens during pregnancy: A multicenter study in Turkey. Advances in Clinical and Medical Microbiology. 2016;1:001.
Festary A, Kouri V, Correa BC, Verdasquera B, Roig T, Couret PM, . Cytomegalovirus and herpes simplex infection in mothers and newborns in a Havana Maternity Hospital. Medic Review. 2015;17(1):29-33
Acharya D, Shrestha A, Bogati B, Khanal K, Shrestha S, Gyawali P, .2014. Serological screening of TORCH agents as an etiology of spontaneous abortion in Dhulikhal Hospital, Nepal. American Journal of Biomedical and Life Sciences. 2014;2(2):34-39
Rathore S, Janwai J, Gupta V. Herpes simplex type 2: Seroprevalence in antenatal women. Indian Journal of Sexually Transmitted Diseases and AIDS. 2010;3(1):11-15.
Nyiro JU, Sanders EJ, Ngetsa C, Wale S, Awouondo K, Bukusi E, et al. Seroprevalence, Predictors and Estimated incidence of maternal and neonatal herpes simplex virus type 2 in semi-urban women in Killifi, Kenya. Biomedical Central Infectious Diseases. 2011;11:153-157
Egbagba J, Mordi RM. Prevalence of asymptomatic genital herpes infection in women attending the antenatal clinics of the University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria. Researcher. 2015;7(11):35-42
Amar OAO, Bajaj HK, Gupta N, Singla A, Masih H . Prevalence of herpes simplex virus in pregnant women from Gangetic Plain Region of Allahabad, India Advances in Microbiology. 2015;5:404- 408.
Pennap GRI, Oti VB. Seroprevalence of Herpes simplex virus type 2 (HSV-2) infection among HIV patients accessing healthcare at Federal Medical Centre, Keffi, Nigeria. Journal of Diagnostics. 2016;3(2):31-37.
Pas-Bailey, Pamaswamy M, Hawkes SJ, Gereti AM. Herpes simplex virus type 2: Epidemiology and Management options in developing countries. Journal of Sexually Transmitted Infections. 2007;83:16-22.
Des Jarlais DC, Arasteli K, McKnight C, Pertman DC, Cooper FH, Hagan H. HSV-2 infection as a cause of female/male and racial/ethnic disparity in HIV infection. Public Library of Science. 2013;8(6): e66874
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
